Associated Papers
Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2.
Kato T et al.
Nature Communications, 2022
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
Bhat S et al.
Pharmacology & Therapeutics, 2021
Transport rate of EAAT2 is regulated by amino acid located at the interface between the scaffolding and substrate transport domains.
Duffield M et al.
Neurochemistry International, 2020
The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein.
Ruggiero AM et al.
The Journal of Biological Chemistry, 2008
Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications.
Cozzolino M et al.
Antioxidants & Redox Signaling, 2008
The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects.
Kanai Y et al.
Pflugers Archiv : European Journal of Physiology, 2004
The glutamate and neutral amino acid transporter family: physiological and pharmacological implications.
Kanai Y et al.
European Journal of Pharmacology, 2003
Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity.
Trotti D et al.
The Journal of Biological Chemistry, 2001
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis.
Aoki M et al.
Annals of Neurology, 1998
Select a paper to view details